샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768729

세계의 간암 진단 시장

Liver Cancer Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 275 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 간암 진단 시장은 2030년까지 220억 달러에 달할 전망

2024년에 143억 달러로 추정되는 세계의 간암 진단 시장은 2024-2030년에 CAGR 7.4%로 성장하며, 2030년에는 220억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 임상 검사는 CAGR 8.4%를 기록하며, 분석 기간 종료시에는 98억 달러에 달할 것으로 예측됩니다. 영상 진단 분야의 성장률은 분석 기간 중 CAGR 7.5%로 추정됩니다.

미국 시장은 37억 달러, 중국은 CAGR 11.1%로 성장 예측

미국의 간암 진단 시장은 2024년에 37억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 53억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 11.1%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.9%와 6.9%로 예측됩니다. 유럽에서는 독일이 CAGR 4.7%로 성장할 것으로 예측됩니다.

세계의 간암 진단 시장 - 주요 동향과 촉진요인 정리

간암 진단은 어떻게 조기 발견 및 치료를 진행하고 있는가?

간암 진단은 빠른 속도로 발전하고 있으며, 치료 옵션이 더 효과적인 초기에 간암을 발견할 수 있는 능력을 향상시키고 있습니다. 간암 진단 툴로는 초음파, 컴퓨터단층촬영(CT), 자기공명영상(MRI) 등의 영상 진단 기술과 알파 태아단백질(AFP) 등의 바이오마커를 측정하는 혈액검사가 있습니다. 간암은 진행될 때까지 자각증상이 거의 없이 조용히 진행되는 경우가 많으므로 조기 발견이 매우 중요합니다. 간염 감염, 알코올 섭취, 비알코올성 지방간질환(NAFLD) 등의 요인으로 인해 전 세계에서 간암 발병률이 증가함에 따라 첨단 진단 툴에 대한 수요가 증가하고 있습니다.

어떤 기술 혁신이 간암 진단 시장을 형성하고 있는가?

진단 기술의 혁신은 간암 발견의 상황을 바꾸고 있습니다. 혈액내 순환종양세포(CTC)와 DNA를 분석하는 비침습적 기술인 액체생검(Liquid Biopsy)은 간암을 검출하고 진행을 모니터링하는 유망한 툴로 부상하고 있습니다. 유전체 프로파일링과 차세대 염기서열 분석(NGS)도 간암 진단에 통합되어 맞춤형 치료 전략의 지침이 되는 특정 유전자 변이를 식별하기 위해 간암 진단에 통합되고 있습니다. 또한 인공지능(AI)과 머신러닝의 발전은 스캔의 해석을 강화하고 기존 방법으로는 발견하기 어려운 조기 종양을 식별함으로써 간암 영상 진단의 정확성을 향상시키고 있습니다.

시장 세분화는 간암 진단의 성장을 어떻게 정의하는가?

기술에는 영상 진단, 액체생검, 바이오마커 검사가 포함되며, 영상 진단은 일상적인 검진에 널리 사용되고 있으므로 가장 큰 부분을 차지합니다. 용도는 조기 발견, 진단 및 모니터링에 이르기까지 다양하며, 의료 서비스 프로바이더가 적시에 개입하여 생존율을 높이기 위해 노력함에 따라 조기 발견이 큰 수요를 주도하고 있습니다. 최종사용자에는 병원, 진단 실험실, 연구기관이 포함되며, 병원은 간암 검진 및 치료 계획의 수가 많기 때문에 주요 부문으로 꼽힙니다. 지역적으로는 중국, 일본 등의 국가에서 간암 유병률이 높기 때문에 아시아태평양에서 시장이 빠르게 성장하고 있습니다.

간암 진단 시장의 성장을 가속하는 요인은 무엇인가?

간암 진단 시장의 성장은 간암 발병률 증가, 진단 기술 발전, 조기 발견에 대한 인식 증가 등 여러 요인에 의해 이루어지고 있습니다. 특히 간염 감염률이 높은 지역에서는 전 세계에서 간암 발생률이 증가하고 있으며, 보다 정확하고 접근하기 쉬운 진단 툴의 필요성이 증가하고 있습니다. 액체생검, AI를 활용한 영상 진단 등의 기술 발전은 조기 발견의 정확도를 높이고, 보다 개인화된 치료 접근법을 가능하게 하고 있습니다. 또한 암 검진 및 조기 진단을 장려하는 정부의 구상은 첨단 진단 툴의 채택을 촉진하여 시장 성장을 더욱 촉진하고 있습니다.

부문

진단 기술( 임상 검사, 영상 진단, 내시경검사, 생검, 기타 진단 기술), 최종사용자(병원·진단 연구소, 학술·연구기관, 기타 최종사용자)

조사 대상 기업의 예

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics U.S.A. Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

AI 통합

검증된 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁합니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.17

Global Liver Cancer Diagnostics Market to Reach US$22.0 Billion by 2030

The global market for Liver Cancer Diagnostics estimated at US$14.3 Billion in the year 2024, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Imaging segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 11.1% CAGR

The Liver Cancer Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Liver Cancer Diagnostics Market - Key Trends and Drivers Summarized

How Is Liver Cancer Diagnostics Advancing Early Detection and Treatment?

Liver cancer diagnostics are undergoing rapid advancements, improving the ability to detect liver cancer at earlier stages when treatment options are more effective. Diagnostic tools for liver cancer include imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), as well as blood tests that measure biomarkers like alpha-fetoprotein (AFP). Early detection is crucial in liver cancer, as the disease often progresses silently with few symptoms until it reaches advanced stages. With rising global rates of liver cancer due to factors such as hepatitis infections, alcohol consumption, and non-alcoholic fatty liver disease (NAFLD), the demand for advanced diagnostic tools is growing.

What Technological Innovations Are Shaping the Liver Cancer Diagnostics Market?

Innovations in diagnostic technologies are transforming the landscape of liver cancer detection. Liquid biopsy, a non-invasive technique that analyzes circulating tumor cells (CTCs) and DNA in the blood, is emerging as a promising tool for detecting liver cancer and monitoring its progression. Genomic profiling and next-generation sequencing (NGS) are also being integrated into liver cancer diagnostics to identify specific genetic mutations that can guide personalized treatment strategies. Additionally, advances in artificial intelligence (AI) and machine learning are improving the accuracy of liver cancer imaging by enhancing the interpretation of scans and identifying early-stage tumors that may be difficult to detect through traditional methods.

How Do Market Segments Define the Growth of Liver Cancer Diagnostics?

Technologies include imaging, liquid biopsy, and biomarker testing, with imaging representing the largest segment due to its widespread use in routine screenings. Applications span early detection, diagnosis, and monitoring, with early detection driving significant demand as healthcare providers focus on improving survival rates through timely intervention. End-users include hospitals, diagnostic laboratories, and research institutions, with hospitals being the primary segment due to the high volume of liver cancer screenings and treatment planning. Geographically, the market is expanding rapidly in Asia-Pacific due to the high prevalence of liver cancer in countries such as China and Japan.

What Factors Are Driving the Growth in the Liver Cancer Diagnostics Market?

The growth in the liver cancer diagnostics market is driven by several factors, including the rising incidence of liver cancer, advancements in diagnostic technologies, and increasing awareness of early detection. As liver cancer rates climb globally, particularly in regions with high hepatitis infection rates, the need for more accurate and accessible diagnostic tools is intensifying. Technological advancements, such as liquid biopsy and AI-enhanced imaging, are improving the precision of early detection, enabling more personalized treatment approaches. Furthermore, government initiatives to promote cancer screenings and early diagnosis are encouraging the adoption of advanced diagnostic tools, further boosting market growth.

SCOPE OF STUDY:

The report analyzes the Liver Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Diagnosis Technique (Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques); End-Use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics U.S.A. Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Liver Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Liver Cancer and Increasing Awareness Drive Growth in Liver Cancer Diagnostics Market
    • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Business Case for Adoption
    • Growing Use of Liquid Biopsies and Biomarker-Based Diagnostics Expands Addressable Market
    • Expansion of Early Detection Programs Fuels Demand for Liver Cancer Diagnostics
    • Increasing Adoption of Non-Invasive Diagnostic Techniques Drives Market Growth
    • Technological Innovations in Next-Generation Sequencing (NGS) Propel Market Growth in Liver Cancer Diagnostics
    • Focus on Enhancing Accuracy and Reducing False Positives Strengthens Demand for Advanced Diagnostic Solutions
    • Growing Use of AI and Machine Learning in Diagnostic Imaging Expands Market Opportunities
    • Rising Demand for Personalized Medicine and Targeted Therapies Fuels Growth in Liver Cancer Diagnostics
    • Technological Advancements in Liquid Biopsy Assays for Early-Stage Detection Propel Market Growth
    • Growing Adoption of Companion Diagnostics in Liver Cancer Treatment Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Diagnosis Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Liver Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제